Skip To The Main Content

FDA Highlights Latest Efforts to Improve Development of New Drugs

The United States Food and Drug Administration (FDA) has highlighted its newest efforts to enhance transparency of clinical trial information to support innovation and scientific inquiry related to new drugs.  To read the FDA announcement and summary of its newest efforts to improve the development of new drugs, use the link below.